Progression of atherosclerosis with carnitine supplementation: a randomized controlled trial in the metabolic syndrome

BACKGROUND: L-carnitine (L-C), a ubiquitous nutritional supplement, has been investigated as a potential therapy for cardiovascular disease, but its effects on human atherosclerosis are unknown. Clinical studies suggest improvement of some cardiovascular risk factors, whereas others show increased p...

Descripción completa

Detalles Bibliográficos
Autores principales: Johri, Amer M., Hétu, Marie-France, Heyland, Daren K., Herr, Julia E., Korol, Jennifer, Froese, Shawna, Norman, Patrick A., Day, Andrew G., Matangi, Murray F., Michos, Erin D., LaHaye, Stephen A., Saunders, Fraser W., Spence, J. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976995/
https://www.ncbi.nlm.nih.gov/pubmed/35366920
http://dx.doi.org/10.1186/s12986-022-00661-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976995/
https://www.ncbi.nlm.nih.gov/pubmed/35366920
http://dx.doi.org/10.1186/s12986-022-00661-9

Ejemplares similares